With the growth of digital health comes a bevy of apps for different devices and health goals. The innovation is spectacular—but could patients get overwhelmed? Rick Anderson of DarioHealth thinks so. “Users may have separate apps for different conditions, and they have coaching and data in these different apps. People can get overwhelmed and drop […]

Protein degradation, cell therapy, synergistic combinations and changes in personalized cancer therapies will drive the next generation of therapeutics, but not necessarily in the ways people might expect. Personalized cancer therapy, for example, seems to be losing ground to other therapies simply because of logistics and finances. “Speed of manufacturing and the cost of getting […]

COVID-19-Related Celltrion Group announced Phase I results from its antibody cocktail of Regkirona and CT-P63. One Phase I study tested CT-P63 in 24 healthy participants in Poland. The trial hit the primary objective of safety and tolerability. It also demonstrated strong neutralizing activity against the Omicron variant. CT-P63 is a monoclonal antibody that targets the SARS-CoV-2 spike […]